Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors

American Journal of Pathology

Volumn 157, Issue 1, 2000, Pages 7-14

  Saaristo, Anne ^a   Partanen, Taina A ^a   Arola, Johanna ^a   Jussila, Lotta ^a   Hytonen, Maija ^b   Makitie, Antti ^b   Vento, Seija ^c   Kaipainen, Arja ^c   Malmberg, Henrik ^b   Alitalo, Kari ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DEVELOPMENT; EMBRYO; GENE EXPRESSION; GENE LOCUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTION; LYMPH VESSEL; MARKER GENE; MOUSE; NASOPHARYNX TUMOR; NONHUMAN; NORTHERN BLOTTING; NOSE MUCOSA; PRIORITY JOURNAL; TUMOR;

EID: 0033888033     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64510-5     Document Type: Article

References (31)

1. Characteristics of capillary permeability in nasal mucosa
2. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
3. Neovasculature induced by vascular endothelial growth factor is fenestrated
4. Vascular endothelial growth factor induces endothelial fenestrations in vitro
5. Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites formation by immunoneutralization
6. Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo
7. Role of vascular endothelial growth factor in the regulation of angiogenesis
8. Kdr receptor: A key marker defining hematopoietic stem cell
9. Vascular endothelial growth factor (VEGF) and its receptors
10. Failure of blood island formation and vasculogenesis in Flk-1-deficient mice
11. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
12. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice
13. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice
14. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
15. Proteolytic processing regulates receptor specificity and activity of VEGF-C
16. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
17. A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation and vascular permeability activities
18. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor
19. Vascular growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
20. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-c
21. Expression of the FLT4 receptor tyrosine kinase becomes restricted to lymphatic endothelium during development
22. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
23. Lack of lymphatic vascular specificity of VEGFR-3 in human vascular tumors
24. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3 in fenestrated endothelia in human tissue
25. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction
26. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3
27. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer
28. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor 3
29. Endothelial growth factor receptors in human fetal heart
30. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors